Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Single-Genome Sequencing of Hepatitis C Virus in Donor-Recipient Pairs Distinguishes Modes and Models of Virus Transmission and Early Diversification.

Li H, Stoddard MB, Wang S, Giorgi EE, Blair LM, Learn GH, Hahn BH, Alter HJ, Busch MP, Fierer DS, Ribeiro RM, Perelson AS, Bhattacharya T, Shaw GM.

J Virol. 2015 Oct 14;90(1):152-66. doi: 10.1128/JVI.02156-15. Print 2016 Jan 1.

2.

Identification, molecular cloning, and analysis of full-length hepatitis C virus transmitted/founder genotypes 1, 3, and 4.

Stoddard MB, Li H, Wang S, Saeed M, Andrus L, Ding W, Jiang X, Learn GH, von Schaewen M, Wen J, Goepfert PA, Hahn BH, Ploss A, Rice CM, Shaw GM.

MBio. 2015 Feb 24;6(2):e02518. doi: 10.1128/mBio.02518-14.

3.

Quantifying the diversification of hepatitis C virus (HCV) during primary infection: estimates of the in vivo mutation rate.

Ribeiro RM, Li H, Wang S, Stoddard MB, Learn GH, Korber BT, Bhattacharya T, Guedj J, Parrish EH, Hahn BH, Shaw GM, Perelson AS.

PLoS Pathog. 2012;8(8):e1002881. doi: 10.1371/journal.ppat.1002881. Epub 2012 Aug 23.

4.

Elucidation of hepatitis C virus transmission and early diversification by single genome sequencing.

Li H, Stoddard MB, Wang S, Blair LM, Giorgi EE, Parrish EH, Learn GH, Hraber P, Goepfert PA, Saag MS, Denny TN, Haynes BF, Hahn BH, Ribeiro RM, Perelson AS, Korber BT, Bhattacharya T, Shaw GM.

PLoS Pathog. 2012;8(8):e1002880. doi: 10.1371/journal.ppat.1002880. Epub 2012 Aug 23.

5.

A phase 1 study of a group B meningococcal native outer membrane vesicle vaccine made from a strain with deleted lpxL2 and synX and stable expression of opcA.

Keiser PB, Gibbs BT, Coster TS, Moran EE, Stoddard MB, Labrie JE 3rd, Schmiel DH, Pinto V, Chen P, Zollinger WD.

Vaccine. 2010 Oct 8;28(43):6970-6. doi: 10.1016/j.vaccine.2010.08.048. Epub 2010 Aug 21.

PMID:
20732470
6.

Design and evaluation in mice of a broadly protective meningococcal group B native outer membrane vesicle vaccine.

Zollinger WD, Donets MA, Schmiel DH, Pinto VB, Labrie JE 3rd, Moran EE, Brandt BL, Ionin B, Marques R, Wu M, Chen P, Stoddard MB, Keiser PB.

Vaccine. 2010 Jul 12;28(31):5057-67.

PMID:
20653107
7.

Evaluation of a whole-blood cytokine release assay for use in measuring endotoxin activity of group B Neisseria meningitidis vaccines made from lipid A acylation mutants.

Stoddard MB, Pinto V, Keiser PB, Zollinger W.

Clin Vaccine Immunol. 2010 Jan;17(1):98-107. doi: 10.1128/CVI.00342-09. Epub 2009 Nov 18.

8.

Propagation of Coxsackie viruses in cultures of human tissues.

WELLER TH, ROBBINS FC, STODDARD MB, FLORENTINO GL.

J Immunol. 1953 Aug;71(2):92-7. No abstract available.

PMID:
13084919
9.
10.

Intranuclear inclusion bodies in cultures of human tissue inoculated with varicella vesicle fluid.

WELLER TH, STODDARD MB.

J Immunol. 1952 Mar;68(3):311-9. No abstract available.

PMID:
14938547
11.

Intranuclear inclusion bodies in tissue cultures inoculated with varicella vesicle fluid.

WELLER TH, STODDARD MB.

AMA Am J Dis Child. 1952 Jan;83(1):75-6. No abstract available.

PMID:
14884741

Supplemental Content

Loading ...
Support Center